Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D7G1JR
|
|||
| Drug Name |
UCB7853
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Parkinson disease [ICD-11: 8A00.0; ICD-10: F02.3, G20; ICD-9: 332] | Phase 1 | [1] | |
| Company |
UCB Biopharma SRL
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Synuclein alpha (SNCA) | Target Info | . | [1] |
| KEGG Pathway | Alzheimer's disease | |||
| Parkinson's disease | ||||
| NetPath Pathway | Leptin Signaling Pathway | |||
| RANKL Signaling Pathway | ||||
| Panther Pathway | Parkinson disease | |||
| Pathway Interaction Database | Alpha-synuclein signaling | |||
| Reactome | Amyloid formation | |||
| WikiPathways | Ectoderm Differentiation | |||
| Parkinsons Disease Pathway | ||||
| Parkin-Ubiquitin Proteasomal System pathway | ||||
| Alzheimers Disease | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04651153) A Multicenter, Participant-Blind, Investigator-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of UCB7853 in Healthy Male Study Participants and Multiple Ascending Doses in Patients With Parkinson's Disease. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.